BRIGHT-4: Large, 'Clean' Trial Clarifies Bivalirudin Benefit

Experts say it’s likely too late for cath labs to stomach a bolus plus infusion, having turned back to heparin once and for all.

Related Keywords

China , Munich , Bayern , Germany , New York , United States , Paris , France General , France , Shenyang , Liaoning , Chicago , Illinois , American , Adnan Kastrati , Yaling Han , Philippe Gabriel Steg , Deutsches Herzzentrum , American Heart Association , General Hospital , Northern Theater Command , Gregg Stone , Icahn School , Mount Sinai , Rod Stables , Liverpool Heart , Chest Hospital , Assistance Publique H , Nail Out ,